• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

作者信息

Harskamp Ralf E, Alexander John H, Lopes Renato D

机构信息

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Amsterdam UMC, University of Amsterdam, Department of General Practice, Amsterdam Cardiovascular Sciences Research Institute, The Netherlands.

Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.

出版信息

Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.

DOI:10.1016/j.ejim.2019.05.018
PMID:31128977
Abstract
摘要

相似文献

1
Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.应对心房颤动合并冠状动脉疾病患者抗栓治疗的复杂局面：来自AUGUSTUS研究的经验教训
Eur J Intern Med. 2019 Jul;65:4-5. doi: 10.1016/j.ejim.2019.05.018. Epub 2019 May 23.
2
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
3
And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?现在我们有了AUGUSTUS研究……它将如何影响接受经皮冠状动脉介入治疗的房颤患者的抗栓治疗？
Eur J Intern Med. 2019 Jul;65:1-3. doi: 10.1016/j.ejim.2019.05.019. Epub 2019 May 23.
4
Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的心房颤动患者的抗血栓治疗。
Cardiol Clin. 2020 Nov;38(4):551-561. doi: 10.1016/j.ccl.2020.07.006. Epub 2020 Sep 17.
5
Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.心房颤动合并冠心病患者的抗栓治疗管理
Clin Ther. 2014 Sep 1;36(9):1176-81. doi: 10.1016/j.clinthera.2014.08.010.
6
Antithrombotics in atrial fibrillation and coronary disease.心房颤动与冠状动脉疾病中的抗栓药物
Expert Rev Cardiovasc Ther. 2014 Aug;12(8):977-86. doi: 10.1586/14779072.2014.937427.
7
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.抗栓治疗在房颤和急性冠脉综合征患者中治疗药物或经皮冠状动脉介入或接受择期经皮冠状动脉介入治疗:从 AUGUSTUS 试验的见解。
Circulation. 2019 Dec 3;140(23):1921-1932. doi: 10.1161/CIRCULATIONAHA.119.043308. Epub 2019 Sep 26.
8
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.接受经皮冠状动脉介入治疗的心房颤动患者的抗栓治疗：北美视角 - 2016年更新
Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004395.
9
Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.心房颤动伴急性或慢性冠状动脉疾病的口服抗血栓治疗。
Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006.
10
[Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].老年冠心病合并心房颤动患者的口服抗凝药
Ann Cardiol Angeiol (Paris). 2018 Dec;67(6):404-410. doi: 10.1016/j.ancard.2018.09.013. Epub 2018 Oct 17.

引用本文的文献

1
Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.经皮冠状动脉介入治疗的心房颤动患者的最佳抗栓治疗方案：一项更新的网络荟萃分析。
JAMA Cardiol. 2020 May 1;5(5):582-589. doi: 10.1001/jamacardio.2019.6175.